Pelvic recurrences post cystectomy: Current treatment strategies

Seminars in Urologic Oncology

Volumn 19, Issue 1, 2001, Pages 45-50

  Schuster, T G ^a   Smith, D C ^a   Montie, J E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Bladder cancer; Pelvic recurrence; Radical cystectomy

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN P53;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CYSTECTOMY; HUMAN; MULTIMODALITY CANCER THERAPY; PELVIS CANCER; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REVIEW;

ABDOMINAL NEOPLASMS; CYSTECTOMY; HUMANS; NEOPLASMS, SECOND PRIMARY; URINARY BLADDER NEOPLASMS;

EID: 0035104211     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Accumulation of nuclear p53 and tumor progression in bladder cancer
2. Should continent diversion be performed in patients with locally advanced bladder cancer?
3. Urinary diversion-related outcome in patients with pelvic recurrence after radical cystectomy for bladder cancer
4. Ileal neobladder and local recurrence of bladder cancer: Patterns of failure and impact on function in men
5. The management of locally recurrent invasive bladder cancer following radical cystectomy
6. Apoptosis and down-staging after preoperative radiotherapy for muscle-invasive bladder cancer
7. Planned irradiation in the management of clinical stage B2-C (T3) bladder carcinoma
8. Randomized trial of cystectomy with or without preoperative radiotherapy for carcinoma of the bilharzial bladder
9. Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: A phase III study
10. Local control of muscle-invasive bladder cancer: Preoperative radiotherapy and cystectomy versus cystectomy alone
11. Five year follow up of a prospective trial of radical cystectomy and neoadjuvant chemotherapy
12. Adjuvant chemotherapy in T3 carcinoma
13. Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder
14. Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: A prospective randomized phase III study
15. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomised controlled trial
16. Phase II evaluation of cisplatin + 5-fluorouracil + radiation therapy in patients with locally advanced/inoperable bladder cancer: A southwest ontology group study 9312
17. Pelvic recurrence after radical cystectomy without preoperative radiation
18. Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder
19. Annular constriction of the rectum secondary to transitional cell carcinoma of the bladder
20. Follow-up after cystectomy for carcinoma of the bladder
21. Transitional cell carcinoma of the bladder: Patterns of recurrence after cystectomy as determined by CT
22. Prognostic factors and significance of chemotherapy in patients with recurrent or metastatic transitional cell cancer of the urinary tract
23. Carboplatin, paclitaxel and gemcitabine in advanced urothelial carcinoma: Updated results
24. Gemcitabine (GEM) plus cisplatin (CDDP) in metastatic transitional cell carcinoma (TCC): Final results of a phase II study
25. Local recurrence after cystectomy alone for bladder carcinoma
26. Preoperative irradiation with and without chemotherapy as adjunct to radical cystectomy
27. Radical cystectomy without radiation therapy for carcinoma of the bladder
28. The relationship of local control to distant metastasis in muscle invasive bladder cancer
29. Long-term patient survival after cystectomy for regional metastatic transitional cell carcinoma of the bladder
30. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-Year followup
31. A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder
32. Radical cystectomy and pelvic lymphadenectomy in the treatment of infiltrative bladder cancer